Kidney stones may increase risk for chronic kidney disease

Kidney stones may damage the kidneys and lead to chronic kidney disease (CKD), according to a paper being presented at the American Society of Nephrology's 41st Annual Meeting and Scientific Exposition in Philadelphia, Pennsylvania.

In extreme cases, individuals with CKD caused by kidney stones may even need dialysis or kidney transplants.

Kidney stones lead to CKD in patients with rare genetic diseases, but it is unclear if they also are an important risk factor for CKD in the general population. In general, researchers have thought that complications of kidney stones can only rarely cause CKD, but studies that have looked at this potential link have been small or have had limited follow-up.

To get a better sense of the role that kidney stones may play in the development of CKD, John Lieske, MD, and his colleagues at the Mayo Clinic in Rochester, Minnesota, studied records of all residents of Olmsted County, MN, over a 20 year span (1984-2003). These data are available through the Rochester Epidemiology Project, a unique and extensive medical documentation system that combines clinical records from the Mayo Clinic and other community providers in the county.

The investigators compared residents diagnosed with kidney stones with individuals without stones, noting who went on to develop CKD as determined by diagnosis codes and laboratory tests. Those with kidney stones were matched 1:3 to controls in the general population so that a total of 4424 stone formers and 10995 controls were identified and followed up, on average, for more than eight years.

The researchers discovered that individuals diagnosed with kidney stones were significantly more likely to subsequently develop CKD. Specifically, stone formers had a 60% greater risk of developing CKD and a 40% increased risk of developing end-stage renal disease (ESRD), the most severe form of CKD.

The study indicates that patients with kidney stones should be carefully evaluated for CKD and its risk factors, and they should be appropriately treated for any that are identified, said Lieske.

Additional studies are needed to determine why patients with kidney stones are at increased risk for CKD. Studies on potential treatment options also are needed, such as studies to determine whether treatments to prevent stone recurrence would reduce risk of further CKD progression.

http://www.asn-online.org/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Clinical trial highlights efficacy of imlifidase for kidney transplant recipients